PROTALIX
Edit

PROTALIX

https://www.protalix.com/
Last activity: 16.04.2024
Categories: DevelopmentMarketProduct
Protalix is dedicated to bringing to market recombinant therapeutic proteins with clinically improved profiles, produced with its ProCellEx® plant cell-based expression system
Mentions
11
Location: Israel, North District, Karmiel
Total raised: $40M

Investors 2

Funding Rounds 1

DateSeriesAmountInvestors
18.02.2021-$40M-

Mentions in press and media 11

DateTitleDescriptionSource
16.04.2024Molecular farming startup Nobell Foods rebrands as Alpine Bi...[Disclosure: AgFunderNews’ parent company AgFunder is an investor in Alpine Bio.] Nobell Foods—a mol...agfunderne...
02.04.2024Casein… from potatoes? Molecular farming startup Finally Foo...Finally Foods—an Israeli molecular farming startup producing dairy proteins in potatoes—has emerged ...agfunderne...
31.01.2024Real coffee… without the beans? Pluri deploys plant cell cul...With demand for coffee expected to dramatically exceed supply as climate change impacts key growing ...agfunderne...
05.05.2023Plant cell culture deep dive: As cracks emerge in botanical ...Plant cell culture has been around for decades, but it hasn’t set the world on fire… yet. So what is...agfunderne...
14.05.2021Protalix BioTherapeutics Reports First Quarter 2021 Financia...prnewswire...
30.03.2021Protalix BioTherapeutics Reports Fiscal Year 2020 Financial ...prnewswire...
18.02.2021Protalix BioTherapeutics Completes Raise of Approximately $4...CARMIEL, Israel, Feb. 18, 2021 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American: PLX) (...salamancap...
18.02.2021Protalix BioTherapeutics Completes Raise of Approximately $4...prnewswire...
26.10.2020Protalix BioTherapeutics to Participate in Virtual Investor ...prnewswire...
12.03.2020Protalix BioTherapeutics Raises $43.7M in FinancingProtalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a Carmiel, Israel-based biopharmace...finsmes.co...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In